Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perineural dexmedetomidine as adjuvant to ropivacaine for adductor canal block
2014-005651-89Phase 2Completed
- Sponsor
- Zealand University Hospital
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postoperative pain comparing Ropivacaine + perineural dexmedetomidine with Ropivacaine + placebo (2 arms). Primary endpoint: Duration of sensory block. Started Jan 2015; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2014-005651-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005651-89.